You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced Medicinal Therapy Product

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial (Inavolisib, Phesgo, Placebo)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Jun 7, 2023

Solid Tumors Trial in Hefei, Shanghai (LCAR-C18S cells)

Recruiting
  • Solid Tumors
  • LCAR-C18S cells
  • Hefei, Anhui, China
  • +2 more
Jun 17, 2022

Osteo Arthritis Knee Trial ("Ready to inject" Umbilical cord-derived Mesenchymal Stromal Cell (MSC) product, Resuspended

Not yet recruiting
  • Osteo Arthritis Knee
  • "Ready to inject" Umbilical cord-derived Mesenchymal Stromal Cell (MSC) product
  • Resuspended Umbilical cord-derived Mesenchymal Stromal Cell (MSC) product
  • (no location specified)
Feb 20, 2023

Sarcopenia Trial in Warsaw (Nandrolone Decanoate, Physiotherapy Intervention, Nutritional Intervention)

Recruiting
  • Sarcopenia
  • Nandrolone Decanoate
  • +3 more
  • Warsaw, Mazowieckie, Poland
    Centrum Wsparcia Badań Klinicznych
Jul 28, 2023

Advanced or Metastatic Solid Tumors Trial in Toulouse, Villejuif, Barcelona (W0101 - Cohort A1, W0101 - Cohort A2, W0101 -

Active, not recruiting
  • Advanced or Metastatic Solid Tumors
  • W0101 - Cohort A1
  • +2 more
  • Toulouse, France
  • +2 more
Dec 19, 2022

Depression Trial in United States (Esketamine, Cognitive Behavioral Therapy (CBT), Antidepressant)

Not yet recruiting
  • Depression
  • New Haven, Connecticut
  • +5 more
Aug 17, 2022

Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor Trial in Petaling Jaya (Dendritic cell + Cytokine-induced killer cell

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Advanced Solid Tumor
  • Dendritic cell + Cytokine-induced killer cell (DC+CIK) immunotherapy
  • Tegafur Only Product
  • Petaling Jaya, Kuala Lumpur, Malaysia
    Clinical Oncology Department, Ummc
Jul 12, 2023

Osteoarthritis of Knee Trial in Bierun (MesoCellA-Ortho administration, HA administration)

Recruiting
  • Osteoarthritis of Knee
  • MesoCellA-Ortho administration
  • HA administration
  • Bieruń, Silesia, Poland
    Galen - Ortopedia Sp. Z O.O.
Mar 29, 2022

Advanced Hepatocellular Carcinoma Trial in Guangzhou (Bifidobacterium Bifidum Oral Product)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Bifidobacterium Bifidum Oral Product
  • Guangzhou, Guangdong, China
    The Third Affiliated Hospital of Sun Yat-Sen University
Nov 16, 2022

Neuroblastoma Trial (GD2 CAR T cells)

Not yet recruiting
  • Neuroblastoma
  • GD2 CAR T cells
  • (no location specified)
Aug 5, 2023

Metastatic Triple-Negative Breast Carcinoma Trial in Barcelona, Madrid, Pamplona (PD1+ TILs (NUMARZU-001) product infusion)

Not yet recruiting
  • Metastatic Triple-Negative Breast Carcinoma
  • PD1+ TILs (NUMARZU-001) product infusion
  • Barcelona, Spain
  • +3 more
Jul 8, 2022

Breast Cancer Metastatic Trial in Guangzhou (Tamoxifen Oral Product)

Completed
Has Results
  • Breast Cancer Metastatic
  • Tamoxifen Oral Product
  • Guangzhou, Guangdong, China
    Sun Yat-sen University, Cancer Center
Mar 25, 2022

Blood Cancer Trial (KCAT19 T cells)

Not yet recruiting
  • Blood Cancer
  • KCAT19 T cells
  • (no location specified)
May 20, 2022

Solid Tumor, Non Small Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck Trial in New Haven, Atlanta, Portland

Recruiting
  • Solid Tumor
  • +3 more
  • New Haven, Connecticut
  • +2 more
Aug 1, 2022

Non-ischemic Dilated Cardiomyopathy Trial in Copenhagen (Allogeneic adipose-derived stromal cells (CSCC_ASC), Control group)

Recruiting
  • Non-ischemic Dilated Cardiomyopathy
  • Allogeneic adipose-derived stromal cells (CSCC_ASC)
  • Control group
  • Copenhagen, Denmark
    The Heart Centre, Rigshospitalet University Hospital Copenhagen,
Jan 15, 2021

Evaluation of FROM-16 in ATMP Patients & Families

Active, not recruiting
  • Family Members
  • Cancer
  • FROM-16 Questionnaire
  • Semi-structured two-part interview
  • Birmingham, United Kingdom
  • +4 more
Aug 15, 2022

Advanced Solid Tumor, Cholangiocarcinoma, Biliary Tract Cancer Trial in Beijing, Jinan, Shanghai (TT-00420, Combination Product:

Not yet recruiting
  • Advanced Solid Tumor
  • +10 more
  • Beijing, China
  • +3 more
Feb 14, 2022

Ovarian Cancer Trial in Italy (Olaparib Oral Product)

Recruiting
  • Ovarian Cancer
  • Olaparib Oral Product
  • Avellino, Italy
  • +4 more
Feb 22, 2022

Diffuse Midline Glioma, H3 K27M-Mutant Trial (GD2 CAR T cells)

Not yet recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • GD2 CAR T cells
  • (no location specified)
Sep 15, 2022

Pancreatic Adenocarcinoma Trial in France (Gene Therapy product CYL-02, Gemcitabine)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • Clichy, France
  • +6 more
Oct 27, 2021

ARDS, Human, COVID Trial in Uppsala (Mesenchymal Stromal Stem Cells - KI-MSC-PL-205)

Active, not recruiting
  • ARDS, Human
  • COVID
  • Mesenchymal Stromal Stem Cells - KI-MSC-PL-205
  • Uppsala, Sweden
    Uppsala University Hospital
Dec 21, 2022

Sarcoma, HER-2 Protein Overexpression Trial in Houston (cells, Pembrolizumab Injectable Product, Nivolumab Injectable Product)

Recruiting
  • Sarcoma
  • HER-2 Protein Overexpression
  • cells
  • +3 more
  • Houston, Texas
    Texas Children's Hospital
Dec 8, 2021

Primary CNS Lymphoma Trial in London (CD19CAR T-cells)

Recruiting
  • Primary CNS Lymphoma
  • CD19CAR T-cells
  • London, United Kingdom
    University College London Hospital
Jun 13, 2022

Kidney Transplantation Trial in Germany (MIC, Standard of Care)

Recruiting
  • Kidney Transplantation
  • MIC
  • Standard of Care
  • Frankfurt, Germany
  • +4 more
Oct 11, 2022

Non Small Cell Lung Cancer Trial in Beijing (HS-10296, Gefitinib)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Beijing, China
    Beijing Cancer Hospital
Jan 19, 2022